Neurocognitive Performance in Public Officials
NCT07650890, Completed, Atlas University
Trial 8
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Neurocognitive Performance in Public Officials | ClinicalTrials.gov |
| NCT number | NCT07650890 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Enrollment | 82 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Atlas University | ClinicalTrials.gov |
| Conditions | Performance, Reaction Time | ClinicalTrials.gov |
| First posted | 2026-06-16 | ClinicalTrials.gov |
| Last updated | 2026-06-16 | ClinicalTrials.gov |
Registered outcomes 5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Muscle Reaction Time | Baseline (single assessment) | Light Trainer® system, which consists of a wireless lighting system with LED pods and a central controller. The participants were seated with their hands on the table, 40 cm apart, palms down, and elbows at 90°. The Light Trainer was positioned centrally 20 cm away from each hand. When the pod was illuminated, the participants were instructed to turn off the light as quickly as possible by touching it. Light activation was randomized to avoid predictability, requiring participants to respond based on light cues each time. In the first task, the participants used their dominant hand to turn off the light as quickly as possible. In the second task, they responded to a light signal by deactivating a predetermined light from two different colors using their dominant hand. Scale Range: No minimum or maximum value in milliseconds (lower time is better). Interpretation: Lower reaction times signify better outcomes, as they reflect faster muscle response to visual stimuli. | ClinicalTrials.gov |
| Secondary | Digit Span Test Performance | Baseline (single assessment) | Assesses attention and working memory using the Digit Span Test. Performance is determined by the maximum number of digits correctly recalled in forward and backward sequences, with higher scores indicating better cognitive performance. | ClinicalTrials.gov |
| Secondary | Stroop Test Performance | Baseline (single assessment) | Assesses selective attention, cognitive flexibility, inhibitory control, and processing speed using the Stroop Test. Performance is determined by the time required to complete the task and the number of errors made during the assessment. | ClinicalTrials.gov |
| Secondary | Quality of Life (SF-36) | Baseline (single assessment) | Assesses health-related quality of life using the Short Form-36 Health Survey (SF-36). The SF-36 consists of 36 items and generates scores ranging from 0 to 100 for each domain, with higher scores indicating better health-related quality of life and better perceived health status across physical and mental health domains. | ClinicalTrials.gov |
| Secondary | Activity-Role Balance Questionnaire | Baseline (single assessment) | Assesses the perceived balance between daily activities and life roles using the Activity-Role Balance Questionnaire (ARBQ). Scores range from 1 to 5, with higher scores indicating a more satisfactory balance between occupational roles and daily activities. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 2
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Digit Span Test | Secondary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)